FORUS Therapeutics Inc

FORUS Therapeutics Inc. a le plaisir d’annoncer que XPOVIO® (sélinexor) bénéficie désormais d’un financement public au Québec depuis le 6 novembre. Pour plus de détails sur les critères, consultez les liens ci-dessous : · Liste des médicaments - Établissement - en vigueur le 6 novembre 2025 (https://lnkd.in/gQi8VDaP) · Liste des médicaments – en vigueur le 6 novembre 2025 (https://lnkd.in/gnGqhjXc)   Nous sommes très heureux de cette avancée importante pour les patients au Québec.   Lisez-le sur notre site web. (https://lnkd.in/gk7WfFTB) #myeloma #bloodcancer #patients #multiplemyeloma #canada #funding

FORUS Therapeutics Inc. is pleased to announce that XPOVIO® (selinexor) is now publicly funded in Quebec as of November 6th. Further details on the criteria can be found in the links below: · Liste des médicaments - Établissement - en vigueur le 6 novembre 2025(https://lnkd.in/gQi8VDaP) · Liste des médicaments – en vigueur le 6 novembre 2025(https://lnkd.in/gnGqhjXc) We are excited about this important milestone for patients in Quebec.  Read on our website.(https://lnkd.in/gjYunDZm) #myeloma #bloodcancer #patients #multiplemyeloma #canada #funding

FORUS Therapeutics is thrilled to welcome Lisa Kolomaya as Therapeutic Area Manager, Hematology/Oncology, AB/SK. Lisa is a results-driven life sciences professional with extensive expertise in both oncology and hematology. Guided by a strategic mindset and passion for innovation, she has consistently worked to advance patient outcomes and enhance the care journey in therapeutic areas she has worked in. With her proactive approach and deep understanding of both the healthcare system and hematology/oncology space, she is well positioned to make a meaningful impact for patients and the broader healthcare community as part of the FORUS team. Welcome Lisa! #pharma #biotech

FORUS Therapeutics is thrilled to welcome Erin Webb as Therapeutic Area Manager, Hematology/Oncology, SW ON. Erin began her career as a physician assistant in the US, caring for patients with both benign and malignant hematologic conditions as well as managing clinical trials and registries. She later transitioned into the biopharmaceutical industry as a Hematology Account Manager with PharmaEssentia where she most recently served as a Regional Training Manager, guiding new hires in disease state knowledge and account management. With her strong clinical background, patient-centered approach, and ability to build meaningful relationships, Erin is well positioned to make a meaningful impact for patients and the healthcare community in her new role at FORUS. Welcome Erin! #pharma #biotech

That’s a wrap on the International Myeloma Society (IMS) 2025 Annual Meeting! 🙌 Our FORUS Therapeutics team was proud to connect with Canadian and global multiple myeloma experts. These conversations and collaborations remind us that advancing care is only possible through strong partnerships and a shared commitment to patients. Thank you to everyone who joined us - we look forward to building on this momentum together. #IMS2025 #MultipleMyeloma #FORUSTherapeutics #TeamFORUS #InCanadaSequenceMatters

We’re thrilled to be at the International Myeloma Society Annual Meeting 2025 in Toronto! 🇨🇦 The FORUS Therapeutics team is proud to join the global myeloma community to share science, exchange insights, and advance our mission of bringing innovative treatments to patients with hematologic cancers. #IMS2025 #Myeloma #FORUSTherapeutics #InCanadaSequenceMatters

📢 Join FORUS Therapeutics at the IMS 2025 We’re proud to be at the International Myeloma Society Annual Meeting in Toronto, September 17–20. Stop by our booth to meet the team and discuss why in 🍁Canada🍁 treatment sequence matters. #IMS2025 #MultipleMyeloma #ForusTherapeutics #OncologyInnovation #SequenceMatters

💡 Light Up for Rare – Rare Disease Day 2025 💡 On February 28, 2025, FORUS Therapeutics joins the global community in raising awareness for the 300 million people worldwide affected by rare diseases. This year’s theme, "Light Up for Rare," is a call to shine a spotlight on the challenges faced by rare disease patients and the urgent need for innovative treatments. At FORUS Therapeutics, we are dedicated to accelerating access to life-changing therapies, particularly for patients facing rare cancers. With only 5% of rare diseases having an approved treatment, we recognize the critical need for action, collaboration, and scientific innovation to bring hope where it’s needed most. ✨ What does it mean to Light Up for Rare? 🔹 Raising Awareness – By amplifying patient voices, we help shed light on the rare disease journey. 🔹 Advancing Innovation – We work tirelessly to bring breakthrough treatments to Canadian patients. 🔹 Strengthening Collaboration – Progress is only possible when patients, researchers, and healthcare professionals unite. 💙 On this Rare Disease Day, we stand in solidarity with the rare disease community, honoring their strength, resilience, and determination. Together, let’s light up the path to a brighter future. #RareDiseaseDay #LightUpForRare #Canada4Rare #FORUSTherapeutics #InnovationForRare #AcceleratingHope #PatientFirst

💡 Light Up for Rare – Rare Disease Day 2025 💡 On February 28, 2025, FORUS Therapeutics joins the global community in raising awareness for the 300 million people worldwide affected by rare diseases. This year’s theme, "Light Up for Rare," is a call to shine a spotlight on the challenges faced by rare disease patients and the urgent need for innovative treatments. At FORUS Therapeutics, we are dedicated to accelerating access to life-changing therapies, particularly for patients facing rare cancers. With only 5% of rare diseases having an approved treatment, we recognize the critical need for action, collaboration, and scientific innovation to bring hope where it’s needed most. ✨ What does it mean to Light Up for Rare? 🔹 Raising Awareness – By amplifying patient voices, we help shed light on the rare disease journey. 🔹 Advancing Innovation – We work tirelessly to bring breakthrough treatments to Canadian patients. 🔹 Strengthening Collaboration – Progress is only possible when patients, researchers, and healthcare professionals unite. 💙 On this Rare Disease Day, we stand in solidarity with the rare disease community, honoring their strength, resilience, and determination. Together, let’s light up the path to a brighter future. #RareDiseaseDay #LightUpForRare #Canada4Rare #FORUSTherapeutics #InnovationForRare #AcceleratingHope #PatientFirst

🌍 World Cancer Day 2025 🌍 Today, on World Cancer Day, we stand united in the global fight against cancer—a disease that impacts millions of lives worldwide. At FORUS Therapeutics Inc., we are dedicated to advancing cancer care by accelerating access to innovative therapies, patient-centered solutions, and bringing hope to those who need it most. We believe in a future where every diagnosis is met with hope and effective treatment. Join us in raising awareness, supporting those impacted, advocating for progress and access to treatments. #WorldCancerDay #UnitedByUnique #FORUSTherapeutics #TogetherWeCan #CancerAwareness #TheLeukemiaLymphomaSocietyofCanada #MyelomaCanada #CanadianMPNNetwork #PatientVoice #HealCanada